• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一些具有强大的抗SARS-CoV-2和抗蛋白酶活性的天然化合物及其类似物,可作为COVID-19药物研发中的先导分子。

Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19.

作者信息

Dinda Biswanath, Dinda Manikarna, Dinda Subhajit, Chakraborty Mithun

机构信息

Department of Chemistry, Tripura University, Suryamaninagar, Agartala, 799022, Tripura, India.

Department of Biochemistry and Molecular Genetics, University of Virginia, School of Medicine, Charlottesville, 1300 Jefferson Park Ave, Va, 22908, USA.

出版信息

Eur J Med Chem Rep. 2022 Dec;6:100079. doi: 10.1016/j.ejmcr.2022.100079. Epub 2022 Aug 28.

DOI:10.1016/j.ejmcr.2022.100079
PMID:36060987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9420082/
Abstract

Currently an emerging human pathogenic coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused coronavirus disease 2019 (COVID-19) that has posed a serious threat to public health worldwide. As it is a novel severe pneumonia-type viral disease, no effective therapeutic agents are available to treat this infection to date, emphasizing an urgent need for development of effective anti-SARS-CoV-2 agents. Based on screening in computational biology and biological in vitro assays, a good number of natural compounds and their synthetic analogues have been confirmed to possess target-specific inhibitory effects against the activity of host and viral proteases, namely, cathepsin-L, TMPRSS2, Sec61, Mpro (3CL-protease), RNA-dependent RNA protease (RdRp), helicase cap-binding proteases eEF1A, eIF4A, eIF4E, which play dominant roles in progression of infection and replication of SARS-CoV-2 virus in host cells. This review paper describes the potent antiviral activity and target-specific anti-proteases activity of some natural compounds and their synthetic analogues against SARS-CoV-2 infection. It will inspire the researchers to unleash their own creativity and to design potent and safe drugs to fight the current COVID-19 pandemic.

摘要

目前,一种新出现的人类致病性冠状病毒,即严重急性呼吸综合征冠状病毒2(SARS-CoV-2),引发了2019冠状病毒病(COVID-19),对全球公共卫生构成了严重威胁。由于这是一种新型的严重肺炎型病毒性疾病,迄今为止尚无有效的治疗药物来治疗这种感染,这凸显了迫切需要开发有效的抗SARS-CoV-2药物。基于计算生物学筛选和体外生物学试验,大量天然化合物及其合成类似物已被证实对宿主和病毒蛋白酶的活性具有靶向特异性抑制作用,这些蛋白酶包括组织蛋白酶-L、跨膜丝氨酸蛋白酶2(TMPRSS2)、信号识别颗粒受体(Sec61)、M蛋白酶(3C样蛋白酶)、RNA依赖性RNA蛋白酶(RdRp)、解旋酶帽结合蛋白酶真核生物延伸因子1A(eEF1A)、真核生物翻译起始因子4A(eIF4A)、真核生物翻译起始因子4E(eIF4E),它们在SARS-CoV-2病毒在宿主细胞中的感染和复制进程中起主导作用。本文综述了一些天然化合物及其合成类似物对SARS-CoV-2感染的强效抗病毒活性和靶向特异性抗蛋白酶活性。它将激励研究人员发挥自己的创造力,设计出强效且安全的药物来对抗当前的COVID-19大流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/d2b7438b0abd/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/ce6fb4600290/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/1c24241a3a2e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/55300df3bae2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/43b697e42299/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/d2b7438b0abd/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/ce6fb4600290/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/1c24241a3a2e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/55300df3bae2/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/43b697e42299/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc00/9420082/d2b7438b0abd/gr4_lrg.jpg

相似文献

1
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19.一些具有强大的抗SARS-CoV-2和抗蛋白酶活性的天然化合物及其类似物,可作为COVID-19药物研发中的先导分子。
Eur J Med Chem Rep. 2022 Dec;6:100079. doi: 10.1016/j.ejmcr.2022.100079. Epub 2022 Aug 28.
2
Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Reporter Assay.基于荧光的高通量 SARS-CoV-2 3CL 报告酶测定法的建立。
J Virol. 2020 Oct 27;94(22). doi: 10.1128/JVI.01265-20.
3
Potent anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L.通过抑制组织蛋白酶L,没食子酰胺A及其类似物具有强大的抗SARS-CoV-2活性。
bioRxiv. 2020 Dec 24:2020.12.23.424111. doi: 10.1101/2020.12.23.424111.
4
In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.计算机筛选鉴定抗 SARS-CoV-2 感染人类蛋白酶的潜在天然产物抑制剂。
Molecules. 2020 Aug 22;25(17):3822. doi: 10.3390/molecules25173822.
5
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.基于计算机的 SARS-CoV-2 潜在砷基获批药物 Darinaparsin 鉴定:RNA 依赖的 RNA 聚合酶(RdRp)和必需蛋白酶抑制剂。
Infect Disord Drug Targets. 2021;21(4):608-618. doi: 10.2174/1871526520666200727153643.
6
Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.开发一种简单且小型化的夹心式荧光偏振分析法用于快速筛选新型冠状病毒主要蛋白酶抑制剂。
Cell Biosci. 2021 Dec 5;11(1):199. doi: 10.1186/s13578-021-00720-3.
7
Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.针对 SARS-CoV-2 生命周期和 COVID-19 细胞因子风暴的天然产物靶向药物发现。
Am J Chin Med. 2022;50(4):927-959. doi: 10.1142/S0192415X22500380.
8
Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.基于结构的虚拟筛选和小分子抑制猫冠状病毒 3CL 蛋白酶的体外检测,作为冠状病毒的替代平台。
Antiviral Res. 2020 Oct;182:104927. doi: 10.1016/j.antiviral.2020.104927. Epub 2020 Sep 7.
9
Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease.鞣酸作为病毒主要蛋白酶和细胞跨膜丝氨酸蛋白酶2(TMPRSS2)的双重抑制剂可抑制新型冠状病毒(SARS-CoV-2)。
Am J Cancer Res. 2020 Dec 1;10(12):4538-4546. eCollection 2020.
10
Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.阿齐霉素、利托那韦、洛匹那韦、奥司他韦、伊维菌素和肝素与 2019 年冠状病毒病和严重急性呼吸综合征冠状病毒-2 3C 样蛋白酶相互作用的分子对接。
J Nanosci Nanotechnol. 2021 Apr 1;21(4):2075-2089. doi: 10.1166/jnn.2021.19029.

引用本文的文献

1
Computational Evaluation and Multi-Criteria Optimization of Natural Compound Analogs Targeting SARS-CoV-2 Proteases.针对新型冠状病毒蛋白酶的天然化合物类似物的计算评估与多标准优化
Curr Issues Mol Biol. 2025 Jul 21;47(7):577. doi: 10.3390/cimb47070577.
2
Selective Control by L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus.L及其类胡萝卜素玉米黄质对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的选择性控制
Int J Mol Sci. 2025 Feb 15;26(4):1667. doi: 10.3390/ijms26041667.
3
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools.

本文引用的文献

1
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.Sec61 抑制剂 Apratoxin S4 能强效抑制 SARS-CoV-2 并具有广谱抗病毒活性。
ACS Infect Dis. 2022 Jul 8;8(7):1265-1279. doi: 10.1021/acsinfecdis.2c00008. Epub 2022 Jun 29.
2
Different Aspects of Emetine's Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19.吐根碱作为一种高效的抗新冠病毒SARS-CoV-2抑制剂的多方面能力
ACS Pharmacol Transl Sci. 2022 May 23;5(6):387-399. doi: 10.1021/acsptsci.2c00045. eCollection 2022 Jun 10.
3
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle.
运用化学计量学工具预测巴西锡叶藤科植物中异喹啉生物碱的抗SARS-CoV-2潜力
Int J Mol Sci. 2025 Jan 13;26(2):633. doi: 10.3390/ijms26020633.
4
PDCD4 restricts PRRSV replication in an eIF4A-dependent manner and is antagonized by the viral nonstructural protein 9.PDCD4 通过依赖于 eIF4A 的方式限制 PRRSV 的复制,并且该作用受到病毒非结构蛋白 9 的拮抗。
J Virol. 2024 May 14;98(5):e0006024. doi: 10.1128/jvi.00060-24. Epub 2024 Apr 1.
5
Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins.基于结构的严重急性呼吸综合征冠状病毒2及其德尔塔和奥密克戎变异株蛋白天然抑制剂的虚拟鉴定
Future Virol. 2023 May;18(7):421-438. doi: 10.2217/fvl-2022-0184. Epub 2023 Jun 1.
6
Computer-aided drug design for virtual-screening and active-predicting of main protease (M) inhibitors against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶(M)抑制剂的虚拟筛选和活性预测的计算机辅助药物设计
Front Pharmacol. 2023 Nov 7;14:1288363. doi: 10.3389/fphar.2023.1288363. eCollection 2023.
7
identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes.鉴定深海真菌生物碱作为严重急性呼吸综合征冠状病毒2、德尔塔和奥密克戎毒株刺突蛋白的潜在抑制剂。
Future Virol. 2023 Oct. doi: 10.2217/fvl-2023-0102. Epub 2023 Oct 26.
8
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.通过天然产物对抗 COVID-19:药物化学家的各种尝试的全面更新。
Molecules. 2023 Jun 20;28(12):4860. doi: 10.3390/molecules28124860.
9
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China.从实验室到病床:中国小分子抗 SARS-CoV-2 药物的创新。
Eur J Med Chem. 2023 Sep 5;257:115503. doi: 10.1016/j.ejmech.2023.115503. Epub 2023 May 18.
10
Prospecting native and analogous peptides with anti-SARS-CoV-2 potential derived from the trypsin inhibitor purified from tamarind seeds.筛选具有抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)潜力的天然及类似肽,这些肽源自从罗望子种子中纯化得到的胰蛋白酶抑制剂。
Arab J Chem. 2023 Aug;16(8):104886. doi: 10.1016/j.arabjc.2023.104886. Epub 2023 Apr 11.
NSP6 在 SARS-CoV-2 复制细胞器生物发生中的作用。
Nature. 2022 Jun;606(7915):761-768. doi: 10.1038/s41586-022-04835-6. Epub 2022 May 12.
4
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities.天然化合物抑制新型冠状病毒nsp13解旋和ATP酶活性。
ACS Pharmacol Transl Sci. 2022 Apr 1;5(4):226-239. doi: 10.1021/acsptsci.1c00253. eCollection 2022 Apr 8.
5
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.成人 COVID-19 住院患者中普乐沙福的临床前和随机 I 期研究。
Life Sci Alliance. 2022 Jan 10;5(4). doi: 10.26508/lsa.202101200. Print 2022 Apr.
6
Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2.评估石蒜科生物碱类似物作为抗 SARS-CoV-2 的天然药物。
FEBS Open Bio. 2022 Jan;12(1):285-294. doi: 10.1002/2211-5463.13337. Epub 2021 Dec 9.
7
Inhibition of the SARS-CoV-2 3CL main protease by plant polyphenols.植物多酚对新型冠状病毒3CL主要蛋白酶的抑制作用。
Food Chem. 2022 Mar 30;373(Pt B):131594. doi: 10.1016/j.foodchem.2021.131594. Epub 2021 Nov 14.
8
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.姜黄素通过多种抗病毒机制抑制 Vero E6 细胞中的体外 SARS-CoV-2 感染。
Molecules. 2021 Nov 16;26(22):6900. doi: 10.3390/molecules26226900.
9
Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences.低剂量吐根碱作为潜在的抗SARS-CoV-2病毒疗法:临床前体外抑制和体内药代动力学证据
Mol Biomed. 2020;1(1):14. doi: 10.1186/s43556-020-00018-9. Epub 2020 Nov 30.
10
Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L.天然产物鹅膏酰胺 A 及其类似物通过抑制组织蛋白酶 L 发挥强大的抗 SARS-CoV-2 活性。
J Med Chem. 2022 Feb 24;65(4):2956-2970. doi: 10.1021/acs.jmedchem.1c01494. Epub 2021 Nov 3.